Understanding how common Polycystic Ovary Syndrome is in Trinidad
Prevalence of Polycystic Ovary Syndrome In Trinidad
This study is trying to find out how many women aged 18 to 45 in Trinidad have Polycystic Ovary Syndrome (PCOS) to help improve awareness and health strategies in the area.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | The University of The West Indies Academic / other |
| Locations | 1 site (Saint Augustine) |
| Trial ID | NCT05937360 on ClinicalTrials.gov |
What this trial studies
This observational study aims to determine the prevalence of Polycystic Ovary Syndrome (PCOS) among women aged 18 to 45 in Trinidad. It will involve a cross-sectional community-based approach, assessing participants for clinical signs of hyperandrogenism and ovulatory dysfunction. The study seeks to fill gaps in knowledge regarding the global prevalence and phenotypic presentation of PCOS, which is a significant cause of female infertility and associated with various chronic health issues. By gathering this data, the study aims to better inform public health strategies and awareness regarding PCOS in the region.
Who should consider this trial
Good fit: Ideal candidates for this study are females aged 18 to 45 who exhibit signs of hyperandrogenism or ovulatory dysfunction.
Not a fit: Patients who are pregnant, postmenopausal, or have undergone certain surgical procedures like hysterectomy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of Polycystic Ovary Syndrome, ultimately benefiting women's health in Trinidad.
How similar studies have performed: While there have been studies on PCOS prevalence globally, this specific focus on Trinidad is novel and may provide unique insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Female, ages 18 to 45 years., all ethnic backgrounds. 2. The participants must have at least one of the following two features: i) Dermatological signs or complains of clinical hyperandrogenism such as unwanted facial or body hair, loss of scalp hair (alopecia) or persistence acne (pimple). ii) Signs or complains of ovulatory dysfunction such as irregular menses (oligomenorrhoea, amenorrhea or polymenorrhoea), history of anovulation or ultrasonographic findings of polycystic ovarian morphology. Exclusion Criteria: 1. Women less than 18 years or older than 45 years 2. Women who are pregnant at the time of evaluation 3. Postmenopausal women 4. Women who had undergone hysterectomy and/or bilateral oophorectomy 5. Anything that would place the individual at increased risk or preclude the individuals compliance with or completion of the study. 6. Unwillingness to participate or difficulty understanding the consent process or the study objectives and requirements.
Where this trial is running
Saint Augustine
- The University of the West Indies — Saint Augustine, Trinidad and Tobago (Recruiting)
Study contacts
- Study coordinator: Stephanie Dr Mohammed, Ph.D.
- Email: stephanie.mohammed@sta.uwi.edu
- Phone: 18687955950
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.